UTAR and 1 Doc Holding Sdn Bhd (One Doc) officially inked a memorandum of agreement (MoA) on 14 December 2020 at Sungai Long Campus.
The MoA was signed by 1 Doc Holding Sdn Bhd Chairman Tengku Dato’ Seri Baderul Zaman Ibni Almarhum Sultan Mahmud and UTAR President Ir Prof Dr Ewe Hong Tat. The signing was witnessed by 1 Doc Holding Sdn Bhd Co-Founder-cum-Managing Director Dr Terrence Teoh Tean Chun and UTAR Institute of Postgraduate Studies and Research Director Assoc Prof Dr Yong Thian Khok.
The signing of the MoA thrusts collaborative aesthetic research between the two corporations on the effectiveness and safety evaluation of the beauty grade device One Doc PicopulseTM for the treatment of melasma among Malaysian women. This initial research will be conducted at One Doc centre located at Klang Valley.
Delivering his remarks at the signing ceremony, Prof Ewe said, “UTAR has always believed in industry collaborations as the way forward for our staff, students and the University. For education to be truly meaningful and progressive, we need to extend learning beyond the books, the computer and the classrooms. Our staff and students, who are also our leaders of tomorrow, need to gain valuable exposure and exchanges with the industry in order to widen their horizons and gather important people and communication skills, in addition to knowledge acquisition.”
He noted that the University has been working with 463 local and international universities and industry corporations, including significant universities in Germany, the United States, United Kingdom, China, Hong Kong, Taiwan, Japan and Singapore, to name a few.
“We believe that good networking among local and international universities and industry partners will only enhance the achievement of our educational mission and goals which we share with the rest of the world. Therefore, I am proud that for the first time, our academics and researchers are collaborating on such a project with One Doc on Aesthetics related to the beauty industry,” he said.
Dr Terrence Teoh, on the other hand, said, “This topic is a new research effort in Malaysia, and we are excited to begin this journey with UTAR in order to help those who are suffering from this skin disorder. One Doc seeks to develop an improved technique and solution that can overcome melasma with the assistance of the University’s expertise. This research about PiscoPulse™ is highly important to show its effectiveness against melasma.”
He added, “One Doc is a multi-award aesthetic centre in Malaysia, founded in 2016 whereby we specialise in PicoPulse™ treatments. Upon opening our first branch in 2016, we have expanded to 17 branches nationwide. Moving forward, we are planning to expand our PicoPulse™ centres continuously across Southeast Asia for the next few years.”
A presentation on PicoPulse™ for the treatment of melasma was also given by 1 Doc Holding Sdn Bhd Director Dr Chin Boon Keat at the ceremony.
The collaborative research has three phases with the initial focus on melasma. Melasma is a type of skin pigmentation disorder that causes brown or grey patches to appear on the skin, primarily on the face, especially among pregnant women. One Doc seeks to develop an improved technique and solution that can overcome melasma with the assistance of the university's expertise.
The second phase will move its focus to study on possible solutions of anti-hair loss among men. Once conclusive studies are derived from these two phases, it will then initiate the third phase with the focus on product development.
With this collaboration, One Doc also welcomes students who wish to learn more about aesthetic to intern at their centre.
Also present at the event were Tengku’s spouse To’ Puan Seri Hidayah Wan Ismail, 1 Doc Holding Sdn Bhd Director Dato’ Loke Yeu Loong, Co-Founder and Director Dr Michael Ong Hong Keat, Director Joel Yap; UTAR Centre for Cancer Research Chairperson Prof Ts Dr Lim Yang Mooi, Faculty of Medicine and Health Sciences (FMHS) Asst Prof Dr Foo Chai Nien, Division of Community and International Networking (DCInterNet) Director Assoc Prof Dr Lai Soon Onn and DCInterNet Deputy Director Dr Chen, I-Chi.
Dr Chin sharing knowledge on One Doc PicoPulse™ for the treatment of melasma
Prof Lim explaining that a total of 37 female patients with melasma disorder will be enrolled in the pilot test for the research study